Gene · 7031
Papers3,695
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,695
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EPIREGULIN creates a developmental niche for spatially organized human intestinal enteroids. | JCI Insight | 2023 | 36821371 | PubTator, text mining | PubMed |
| Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. | PLoS One | 2023 | 36812168 | PubTator, text mining | PubMed |
| Codon adaptation by synonymous mutations impacts the functional properties of the estrogen receptor-alpha protein in breast cancer cells. | Mol Oncol | 2023 | 36808875 | PubTator, text mining | PubMed |
| Physiological hypoxia improves growth and functional differentiation of human intestinal epithelial organoids. | Front Immunol | 2023 | 36793710 | PubTator, text mining | PubMed |
| The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin. | Proc Natl Acad Sci U S A | 2023 | 36791099 | PubTator, text mining | PubMed |
| Synthetic analysis of chromatin tracing and live-cell imaging indicates pervasive spatial coupling between genes. | Elife | 2023 | 36790144 | PubTator, text mining | PubMed |
| The Tumorigenic Role of Circular RNA-MicroRNA Axis in Cancer. | Int J Mol Sci | 2023 | 36769372 | PubTator, text mining | PubMed |
| Neurotrophins in the Neuropathophysiology, Course, and Complications of Obstructive Sleep Apnea-A Narrative Review. | Int J Mol Sci | 2023 | 36768132 | PubTator, text mining | PubMed |
| EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status. | Cancers (Basel) | 2023 | 36765632 | PubTator, text mining | PubMed |
| Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population. | Cancer Epidemiol | 2023 | 36758349 | PubTator, text mining | PubMed |
| Chromatin Regulator-Related Gene Signature for Predicting Prognosis and Immunotherapy Efficacy in Breast Cancer. | J Oncol | 2023 | 36755810 | PubTator, text mining | PubMed |
| Signal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes. | Nat Struct Mol Biol | 2023 | 36747093 | PubTator, text mining | PubMed |
| The mechanism and therapy of aortic aneurysms. | Signal Transduct Target Ther | 2023 | 36737432 | PubTator, text mining | PubMed |
| Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary. | Am J Surg Pathol | 2023 | 36730833 | PubTator, text mining | PubMed |
| Hsa_circ_0005273 acts as a sponge of miR-509-3p to promote the malignant behaviors of breast cancer by regulating HMMR expression. | Thorac Cancer | 2023 | 36727613 | PubTator, text mining | PubMed |
| The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon. | Immunity | 2023 | 36720220 | PubTator, text mining | PubMed |
| Generation of human alveolar epithelial type I cells from pluripotent stem cells. | bioRxiv | 2023 | 36711505 | PubTator, text mining | PubMed |
| Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer. | JHEP Rep | 2023 | 36699667 | PubTator, text mining | PubMed |
| Low expression of the dynamic network markers FOS/JUN in pre-deteriorated epithelial cells is associated with the progression of colorectal adenoma to carcinoma. | J Transl Med | 2023 | 36698183 | PubTator, text mining | PubMed |
| TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis. | Cancer Res | 2023 | 36696357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7031/papers?page=18